Surrey, Eric

No ORCID on file · 9 papers in corpus · active 2018-2021

Study types

  • other 7
  • article 2

Condition tags

  • endometriosis 9
  • dysmenorrhea 2
article 2021
Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
·doi:10.6084/m9.figshare.14795093

Additional file 1: Supplemental Table 1. Endometriosis Health Profile-30 at month 3 – pain; Supplemental Table 2. Endometriosis Health Profile-30 at month 3 – control and powerlessness; Supplemental Table 3. Endometriosis Health Profile-30 …

article 2021
Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
·doi:10.6084/m9.figshare.14795093.v1

Additional file 1: Supplemental Table 1. Endometriosis Health Profile-30 at month 3 – pain; Supplemental Table 2. Endometriosis Health Profile-30 at month 3 – control and powerlessness; Supplemental Table 3. Endometriosis Health Profile-30 …

other 2021
Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
·doi:10.6084/m9.figshare.c.5470895

Abstract Background Elagolix is an oral, gonadotropin-releasing hormone (GnRH) receptor antagonist, that significantly reduces dysmenorrhea and non-menstrual pelvic pain (NMPP) in women with moderate to severe endometriosis-associated pain.…

other 2021
Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
·doi:10.6084/m9.figshare.c.5470895.v1

Abstract Background Elagolix is an oral, gonadotropin-releasing hormone (GnRH) receptor antagonist, that significantly reduces dysmenorrhea and non-menstrual pelvic pain (NMPP) in women with moderate to severe endometriosis-associated pain.…

other 2020
Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
·doi:10.6084/m9.figshare.11417625.v2

Provide enhanced digital features for this article This Figshare page contains a Summary Slide. If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adi…

other 2019
Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
·doi:10.6084/m9.figshare.11417625.v1

Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime,…

other 2019
Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
·doi:10.6084/m9.figshare.11417625

Provide enhanced digital features for this article This Figshare page contains a Summary Slide. If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adi…

other 2018
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
·doi:10.6084/m9.figshare.6106538

Article full text The full text of this article can be found here. Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please cont…

other 2018
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
·doi:10.6084/m9.figshare.6106538.v1

Article full text The full text of this article can be found here. Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please cont…